Fresenius Medical Care AG & Co KGaA ST buy GMSE
Start price
11.05.23
/
50%
€44.75
Target price
11.05.24
-
Performance (%)
-9.28%
Price
30.04.24
€39.41
This prediction will end soon
Summary
This prediction is currently active. With a performance of -9.28%, the BUY prediction by GMSE is trending in the wrong direction. Dividends of €1.19 are taken into consideration when calculating the performance. This prediction currently runs until 11.05.24. The prediction end date can be changed by GMSE at any time. GMSE has 50% into this predictionFresenius Medical Care is a leading global provider of dialysis products, services and care, particularly for patients with chronic kidney disease. It operates in over 120 countries and cares for over 345,000 patients worldwide. The company specializes in renal care, manufacturing and distributing products related to dialysis and providing clinical care as well as education and support services for patients with kidney disease. Fresenius Medical Care has been listed on the Frankfurt Stock Exchange since 1996 and on the New York Stock Exchange since 1997. Its symbol, FMCQF, represents its over-the-counter (OTC) stock symbol in the United States.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Fresenius Medical Care AG & Co KGaA ST | 1.520% | 1.520% |
| iShares Core DAX® | -0.992% | -3.231% |
| iShares Nasdaq 100 | -0.225% | -3.339% |
| iShares Nikkei 225® | -0.736% | -7.859% |
| iShares S&P 500 | -0.509% | -2.979% |
Comments by GMSE for this prediction
In the thread Fresenius Medical Care AG & Co KGaA ST diskutieren
GMSE hat das Wertpapier Fresenius Medical Care AG & Co KGaA ST in seinem Wikifolio Global Top20 gekauft.